Zhu Jie J - OmicsDI

Show results for

Unknown (110)
Proteomics (61)
Transcriptomics (8)
Metabolomics (8)
Genomics (6)
Multiomics (3)

Organisms

Homo sapiens (48)
Mus musculus (11)
Zea mays (2)
Saccharomyces cerevisiae (2)
Arabidopsis thaliana (2)
Caenorhabditis elegans (1)
Nicotiana tabacum (1)
Plasmodium falciparum (1)
Eriocheir sinensis (1)
Mus (1)
Neofusicoccum parvum (1)
Rattus norvegicus (1)
Sus scrofa (1)
Acinetobacter baylyi ADP1 (1)
Oryctolagus cuniculus (1)

Repository

iProX (49)
biostudies-arrayexpress (9)
pride (9)
MetaboLights (8)
EGA (5)
PeptideAtlas (3)

Tissue

Liver (7)
Others (3)
Cell culture (2)
Hepatocyte (1)
Permanent cell line cell (1)

Disease

Skin cancer (1)

Technology Type

Mass Spectrometry (9)
Mass spectrometry (7)
Data-dependent acquisition (3)
SWATH MS (3)
Shotgun proteomics (3)
SRM/MRM (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
Bottom-up proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
LTQ Orbitrap Elite (2)
Illumina HiSeq 2000 (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - Negative (LC-MS (Neg)) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Pos)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - positive - hilic (1)
Xevo G2-XS QTOF (Waters) (1)
Xevo QTof MS (Waters) (1)
QExactive (1)

Publication Date

2024 (11)
2022 (11)
2020 (10)
2021 (8)
2014 (7)
2026 (6)
2025 (6)
2017 (4)
2023 (4)
2019 (4)
2018 (3)
2015 (2)
2012 (1)
2007 (1)

UNIPROT ID/AC

A0A024R563 (3)
A0A024R8H9 (3)
A0A024RAN2 (3)
A0A024RC46 (3)
A0A087WUD1 (3)
A0A087WVZ5 (3)
A0A087WWK8 (3)
A0A087WXI0 (3)
A0A087WZE9 (3)
A0A087X1S3 (3)
A0A0A0MR66 (3)
A0A0A0MS51 (3)
A0A0A0MSA7 (3)
A0A0B4J220 (3)
A0A0C4DG89 (3)
A0A0C4DGT3 (3)
A0AV96 (3)
A0AVT1 (3)
A0FGR8 (3)
A0FGR8-2 (3)
A0FGR8-6 (3)
A0JLT2 (3)
A0JNW5 (3)
A0MZ66 (3)
A0PJW6 (3)
A0PK00 (3)
A1A4S6 (3)
A1L0T0 (3)
A1L170 (3)
A1L390 (3)

ENSEMBL ID

ENSG00000147251 (3)
ENSG00000170477 (3)
ENSG00000247315 (3)

CHEBI ID

CHEBI:27897 (3)
CHEBI:28044 (3)
CHEBI:30769 (3)
CHEBI:132538 (2)
CHEBI:134594 (2)
CHEBI:15428 (2)
CHEBI:15891 (2)
CHEBI:16335 (2)
CHEBI:16737 (2)
CHEBI:16811 (2)
CHEBI:16870 (2)
CHEBI:16919 (2)
CHEBI:16990 (2)
CHEBI:17268 (2)
CHEBI:17376 (2)
CHEBI:17822 (2)
CHEBI:17992 (2)
CHEBI:18186 (2)
CHEBI:18211 (2)
CHEBI:18237 (2)
CHEBI:18257 (2)
CHEBI:22653 (2)
CHEBI:22660 (2)
CHEBI:25017 (2)
CHEBI:25094 (2)
CHEBI:26271 (2)
CHEBI:26986 (2)
CHEBI:27266 (2)
CHEBI:27570 (2)
CHEBI:28300 (2)

Metabolite Name

23-Nordeoxycholic acid (2)
7-Ketolithocholic acid (2)
Arginine (2)
Cholic acid (2)
Citric acid (2)
Eicosapentaenoic acid (2)
Gluconolactone (2)
Hippuric acid (2)
Hypoxanthine (2)
Inositol (2)
L-Malate (2)
Lithocholic acid (2)
Mevalonic acid (2)
P-Toluenesulfonic acid (2)
Palmitic acid (2)
Pantothenic acid (2)
Pseudouridine (2)
Salicylic acid (2)
Sebacic acid (2)
Sucrose (2)
Taurine (2)
Uric acid (2)
Uridine (2)
Xanthine (2)
Xanthosine (2)
(+)-Syringaresinol (1)
(+/-)11(12)-EET (1)
(+/-)12(13)-DiHOME (1)
(+/-)5(6)-DiHET (1)
(+/-)9(10)-EpOME (1)

Study type

RNA-seq of coding RNA (5)
ChIP-chip by array (1)
Methylation profiling by high throughput sequencing (1)
Transcription profiling by SAGE (1)
Transcription profiling by tiling array (1)

Release Date

2025 (17)
2024 (15)
2023 (15)
2022 (15)
2020 (12)
2026 (7)
2021 (7)
2019 (6)
2015 (5)
2018 (5)
2014 (4)
2016 (4)
2017 (3)
2013 (2)
2012 (1)
2007 (1)

Lab affiliation

1. Department of Biochemistry and Molecular Cell Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine. (2)
Department of Clinical Pharmacy, University of Michigan (2)
Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor, MI (1)
Department of Clinical Pharmacy, University of Michigan College of Pharmacy (1)
Immunogenetics Laboratory, Shenzhen Blood Center, Shenzhen 518040, China (1)
Shanghai Veterinary Research Institute,Chinese Academy of Agricultural Sciences (1)
Sichuan university (1)

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

An effective solution to discover synergistic drugs for anti-cerebral ischemia from traditional Chinese medicinal formulae.

Recently, the pharmaceutical industry has shifted to pursuing combination therapies that comprise more than one active ingredient. Interestingly, combination therapies have been used for more than 2500 years in traditional Chinese medicine (TCM). Understanding optimal proportions and synergistic mec...

S-EPMC3827340 | biostudies-literature

Huang Lian Jie Du Decoction enhances the anti-tumor efficacy of immune checkpoint inhibitors by activating TLR7/8 signalling in melanoma.

Background

The clinical application of immune checkpoint inhibitors (ICIs) is limited by their drug resistance, necessitating the development of ICI sensitizers to improve cancer immunotherapy outcomes. Huang Lian Jie Du Decoction (HLJD, Oren-gedoku-to in Japanese, Hwangryunhaedok-tang in Ko...

S-EPMC11007990 | biostudies-literature

Huang-Lian-Jie-Du decoction alleviates cognitive impairment in periodontitis rats through restoring microbiota-gut-brain axis and inhibiting neuroinflammation via TLR4/NF-κB pathway.

Background

Huang-Lian-Jie-Du decoction (HLJDD), a typical formulation for heat clearance and detoxification, shows therapeutic potential for oral diseases and cognitive impairment. Nevertheless, the mechanism by which HLJDD influences periodontitis-induced cognitive impairment via the microb...

S-EPMC12548159 | biostudies-literature

Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.

Objective

To systematically assess the clinical efficacy of the Jie Yu Wan (JYW) formula in treating generalized anxiety disorder (GAD).

Methods

A multicenter, prospective, double-blind, double-dummy, randomized controlled trial (RCT) was conducted at four hospitals in China. A...

S-EPMC9012658 | biostudies-literature

Different treatment strategies and molecular features between right-sided and left-sided colon cancers.

The colon is derived from the embryological midgut and hindgut separately, with the right colon and left colon having different features with regards to both anatomical and physiological characteristics. Cancers located in the right and left colon are referred to as right colon cancer (RCC) and left...

S-EPMC4458758 | biostudies-literature

PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis.

There is currently a lack of biomarkers to assist the diagnosis and prediction of primary gouty arthritis (PG). Therefore, we evaluated the clinical value of programmed cell death protein 1 (PD-1) mRNA expression in peripheral blood mononuclear cells (PBMCs) of patients with PG. This study included ...

S-EPMC7417685 | biostudies-literature

Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia.

Objective

Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality. Current research has focused on endothelial dysfunction regarding pathogenesis of preeclampsia. However, very limited or no studies so far have been performed to assess possible damaged endothelial c...

S-EPMC5649442 | biostudies-literature

Efficacy and safety of acupuncture-related therapies in symptomatic endometriosis: a systematic review and network meta-analysis.

Objective

To compare the effectiveness and safety of different acupuncture-related therapies combined with pharmacotherapies for treating symptomatic endometriosis.

Methods

A pre-defined search strategy was conducted across eight databases (Chinese Biomedical Literature Service System...

S-EPMC11920332 | biostudies-literature

Quantitative transcriptome analysis of a high-GSH producing Saccharomyces cerevisiae and the wild type based on the second generation sequencing.

The mutant Saccharomyces cerevisiae Y518 generated much more intracellular glutathione (GSH) than its counterpart dose. The RNA-seq based global transcriptome analysis was performed for exploring the potential mechanisms. Statistical analysis indicated that 1125 differentially expressed genes (fold-...

ORGANISM(S): Saccharomyces cerevisiae

2014-06-07 | E-GEOD-47787 | biostudies-arrayexpress

Risks of stroke and myocardial infarction after retinal artery occlusion and their time dependence: a systematic review and meta-analysis.

Background

Retinal artery occlusion (RAO) is an ophthalmic emergency that may signal underlying cardiovascular disease. Both stroke and myocardial infarction (MI) share pathophysiological mechanisms and risk factors with RAO. This systematic review aimed to assess the risks of stroke and MI ...

S-EPMC12537614 | biostudies-literature

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

193 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

Background

Background

Objective

Methods

Objective

Objective

Methods

Background

OmicsDI is part of the ELIXIR infrastructure

Tweets